Stay updated on E2609 Dose-Finding in Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the E2609 Dose-Finding in Alzheimer's Disease Clinical Trial page.

Latest updates to the E2609 Dose-Finding in Alzheimer's Disease Clinical Trial page
- CheckyesterdayChange DetectedAdded a dedicated Locations section listing participating states (CA, FL, GA, KS, MI, NJ, NC, OH, SC, TX) and updated the study record to revision v3.3.3.SummaryDifference1.0%

- Check8 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page shows a version upgrade from v3.2.0 to v3.3.2 with UI improvements; study details, eligibility criteria, and locations appear unchanged.SummaryDifference0.0%

- Check31 days agoChange DetectedNotice about government funding and NIH operating status was removed from the page. The notice was a general site-wide message and did not pertain to the study's details, eligibility criteria, or results.SummaryDifference0.3%

- Check45 days agoChange DetectedThe study record details remain the same across screenshots, with only formatting differences observed. No substantive data or page functions appear to have changed.SummaryDifference0.3%

- Check74 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference2%

- Check81 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.3%

Stay in the know with updates to E2609 Dose-Finding in Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the E2609 Dose-Finding in Alzheimer's Disease Clinical Trial page.